MarketCatalyst
← Back to Research
Earnings

Cigna Beats Q3 2026 Estimates as Revenue Rises 5.6% to $73.68B

Revenue of $73.68B vs. $72.64B expected and adjusted EPS of $7.98 vs. $7.52; revenue up 5.6% from a year earlier.

Published Nov 5, 2026 · 6:01 AM ET · 2 min read

Cigna (CI) beat estimates for the third quarter of 2026 on both revenue and adjusted EPS. Revenue was $73.68 billion, up 5.6% from a year earlier, above the $72.64 billion estimate, and adjusted EPS was $7.98, up 1.9% from a year earlier, above the $7.52 estimate.

$7.98
Adjusted EPS, up 1.9% YoY vs. $7.52 estimate
$73.68B
Revenue, up 5.6% YoY vs. $72.64B estimate
7 of 8
EPS beats in the last 8 reports

Q3 2026 scorecard

ParametersExpectedActualBeat/Miss
Adjusted EPS$7.52$7.98Beat by 6.1%
Revenue$72.64B$73.68BBeat by 1.4%
ChangeYoYQoQ
Adjusted EPS▲ 1.9%▲ 2.6%
Revenue▲ 5.6%▲ 2.8%

By our calculation, revenue was $1.05 billion above the estimate and adjusted EPS was $0.46 above it. The QoQ column compares with the previous quarter's revenue of $71.67 billion and adjusted EPS of $7.78. The YoY column compares with $69.75 billion and $7.83 in the same quarter a year earlier.

Track record

  • EPS record. Adjusted EPS beat the estimate in 7 of the last 8 reports, including this one.
  • Revenue record. Revenue beat the estimate in 8 of the last 8 reports.
  • Revenue trend. Revenue over the last 5 reports, oldest first: $69.75 billion, $72.47 billion, $68.49 billion, $71.67 billion and $73.68 billion.

What to watch

  • Next-quarter estimates. Consensus calls for EPS of $7.41 and revenue of $74.92 billion next quarter, based on 14 analysts.
  • Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 5.6% increase to $73.68 billion.
  • Estimate record. Whether Cigna extends a record of beating EPS estimates in 7 of its last 8 reports.
  • Related coverage. See our reports on Northwest Natural, Air Products and Chemicals, Dorian LPG and Oscar Health.

Sources: Results are from Cigna's Nov. 5, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Cigna's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.

Readers also read

MarketCatalyst is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.

Cigna Beats Q3 2026 Estimates